Effect [qlco]
tibolone [phsu, strd]
Continuous [idcn]
Combined [qlco]
Conjugated [spco]
Equine [mamm]
Oestrogens [horm, phsu, strd]
medroxyprogesterone acetate [horm, phsu, strd]
progression [patf]
Carotid [bpoc]
Intima media thickness [clna]
Osteoporosis [dsyn]
Prevention [topp]
Arterial [bpoc]
effects [qlco]
tibolone [phsu, strd]
OPAL [topp]
Study [mnob]
Aims [idcn]
Time [tmco]
Design [acty]
Osteoporosis [dsyn]
Prevention [topp]
Arterial [bpoc]
effects [qlco]
tibolone [phsu, strd]
OPAL [topp]
Study [mnob]
Oral [spco]
Hormone Therapy [topp]
Assumed [inpr]
To [qlco]
CARDIOVASCULAR [bdsy]
Risk [qlco]
Evidence [ftcn]
effects [qlco]
Of [spco]
Combined therapy [topp]
Conjugated oestrogens + Medroxyprogesterone [horm, phsu, strd]
Equine [mamm]
Plus [qlco]
Acetate [orch, phsu]
Hormone Therapy [topp]
Not [ftcn]
Study [mnob]
tibolone [phsu, strd]
Tissue [tisu]
Estrogenic [horm, orch, phsu]
activity [dora]
REGULATOR [medd]
Several [qnco]
effects [qlco]
cardiovascular risk factor [dsyn]
One [qnco]
lowering [spco]
Overall [inpr]
Effect [qlco]
tibolone [phsu, strd]
CARDIOVASCULAR [bdsy]
Risk [qlco]
Unknown [qlco]
OPAL [topp]
Study [mnob]
Design [acty]
Methods [inpr]
Result [ftcn]
OPAL [topp]
Study [mnob]
Three [qnco]
Arm [blor]
randomized [resa]
placebo-controlled [resa]
Double-Blind Study [resa]
Effect [qlco]
tibolone [phsu, strd]
mg% [qnco]
Daily [tmco]
Of [spco]
Combined [qlco]
Conjugated oestrogens + Medroxyprogesterone [horm, phsu, strd]
Equine [mamm]
Plus [qlco]
Acetate [orch, phsu]
mg% [qnco]
Daily [tmco]
progression [patf]
Carotid Intima-Media Thickness [clna]
Health [idcn]
Post-Menopause [orgf]
Women [popg]
Women [popg]
Six [qnco]
Five [qnco]
European [popg]
centres [spco]
Primary [qlco]
Outcome [ftcn]
Change [ftcn]
Mean [qnco]
Common [qnco]
Carotid Intima-Media Thickness [clna]
Annual [tmco]
Common [qnco]
Carotid Intima-Media Thickness [clna]
progression [patf]
Rate [acty]
tibolone [phsu, strd]
Combined [qlco]
Conjugated oestrogens + Medroxyprogesterone [horm, phsu, strd]
Equine [mamm]
Plus [qlco]
Acetate [orch, phsu]
Group [idcn]
High [qlco]
placebo [topp]
Group [idcn]
Confidence Interval [qnco]
tibolone [phsu, strd]
Group [idcn]
In [qnco]
Combined [qlco]
Conjugated oestrogens + Medroxyprogesterone [horm, phsu, strd]
Equine [mamm]
Plus [qlco]
Acetate [orch, phsu]
Group [idcn]
placebo [topp]
Group [idcn]
placebo [topp]
tibolone [phsu, strd]
For [qlco]
Combined [qlco]
Conjugated oestrogens + Medroxyprogesterone [horm, phsu, strd]
Equine [mamm]
Plus [qlco]
Acetate [orch, phsu]
statistically significant [qnco]
Cholesterol, HDL [bacs, lipd]
Increased [qnco]
In [qnco]
Combined [qlco]
Conjugated oestrogens + Medroxyprogesterone [horm, phsu, strd]
Equine [mamm]
Plus [qlco]
Acetate [orch, phsu]
Group [idcn]
lowered [spco]
tibolone [phsu, strd]
Group [idcn]
Conclusion [idcn]
tibolone [phsu, strd]
Combined [qlco]
Conjugated oestrogens + Medroxyprogesterone [horm, phsu, strd]
Equine [mamm]
Plus [qlco]
Acetate [orch, phsu]
Show [inpr]
Increased [qnco]
progression [patf]
Common [qnco]
Carotid Intima-Media Thickness [clna]
Translation [inpr]
Increased [qnco]
Common [qnco]
Carotid Intima-Media Thickness [clna]
progression [patf]
Of [spco]
Combined [qlco]
Conjugated oestrogens + Medroxyprogesterone [horm, phsu, strd]
Equine [mamm]
Plus [qlco]
Acetate [orch, phsu]
Group [idcn]
Cardiovascular disease [dsyn]
Risk [qlco]
Not [ftcn]
Observed [ftcn]
Increased [qnco]
CARDIOVASCULAR [bdsy]
Risk [qlco]
Observed [ftcn]
Initiative [menp]
Study [mnob]
This [euka]
Suggest [idcn]
Reticular [spco]
Effect [qlco]
tibolone [phsu, strd]
Combined [qlco]
Conjugated oestrogens + Medroxyprogesterone [horm, phsu, strd]
Equine [mamm]
Plus [qlco]
Acetate [orch, phsu]
cardiovascular events [fndg]
depend [medd]
Combined [qlco]
effects [qlco]
Arterial wall [bpoc]
Clotting factors [aapp, bacs, phsu]
Possibly [qlco]
Inflammation [patf]
